Mitoxantrone and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Mitoxantrone (mitoxantrone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Doxycycline, and have Abdominal discomfort.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Mitoxantrone. It is created by eHealthMe based on reports of 8,117 people who have side effects when taking Mitoxantrone from the FDA, and is updated regularly.

What is Mitoxantrone?

Mitoxantrone has active ingredients of mitoxantrone hydrochloride. eHealthMe is studying from 8,125 Mitoxantrone users. Check the latest studies of Mitoxantrone.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,494 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 10, 2026

8,117 people reported to have side effects when taking Mitoxantrone.
Among them, 13 people (0.16%) have Visual acuity reduced.

Could Mitoxantrone cause Visual acuity reduced?

Among these 13 people:

How long have people been on Mitoxantrone when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Mitoxantrone? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Visual acuity reduced when taking Mitoxantrone? *

What are other drugs people take besides Mitoxantrone? *

What are other side effects people have besides Visual acuity reduced? *

Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 7 people, 53.85%
Pneumonia: 5 people, 38.46%
Thrombocytopenia (decrease of platelets in blood): 4 people, 30.77%
Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 4 people, 30.77%
Retinal Degeneration (death of the cells of the retina): 4 people, 30.77%
Retinal Infiltrates (the yellow-white area with fuzzy edges is a retinal infiltrate): 4 people, 30.77%
Haemorrhage (bleeding): 4 people, 30.77%
Pain: 4 people, 30.77%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 4 people, 30.77%
Memory Loss: 4 people, 30.77%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 23.08%
High Blood Pressure: 3 people, 23.08%
Abdominal Discomfort: 3 people, 23.08%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 15.38%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 15.38%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 1 person, 7.69%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.69%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
Metastases To Bone (cancer spreads to bone): 1 person, 7.69%
Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mitoxantrone and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mitoxantrone:

Mitoxantrone (8,125 reports)

Browse all side effects of Mitoxantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,494 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mitoxantrone hydrochloride (the active ingredients of Mitoxantrone) and Mitoxantrone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.